Evidence map›Paper›PMID 35875670›Full record

ArticleFrontiers in molecular neuroscience2022

Breaking Mental Barriers Promotes Recovery After Spinal Cord Injury.

Haven I Rodocker, Arman Bordbar, Molly J E Larson, Rebecca G Biltz, Lynde Wangler, Paolo Fadda, Jonathan P Godbout, Andrea Tedeschi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Gabapentin and cognitive impairment after traumatic brain injury: A multinational cohort of 49,925 patients.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Haven I RodockerDepartment of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Arman BordbarDepartment of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Molly J E LarsonDepartment of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Rebecca G BiltzDepartment of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Lynde WanglerDepartment of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Paolo FaddaDepartment of Cancer Biology, The Ohio State University, Columbus, OH, United States.
Jonathan P GodboutDepartment of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
Andrea TedeschiDepartment of Neuroscience, Wexner Medical Center, The Ohio State University, Columbus, OH, United States.
The Ohio State University Wexner Medical Center · USThe Ohio State University · USInstitute for Behavioral Medicine · US

Funding

Chronic and Evolving Inflammation after Traumatic Brain Injury: Microglial Priming and Neuropsychiatric ComplicationsR01NS118037 · NINDS · OHIO STATE UNIVERSITY · PI GODBOUT, JONATHAN P · 2021 to 2025
$2.2M
Ohio State University Neuroscience Center Core-Core EP30NS104177 · NINDS · OHIO STATE UNIVERSITY · PI BROWN, ANTHONY · 2017 to 2020
$1.9M
Targeting Non-Neuronal Mechanisms for Spinal Cord Injury RepairR01NS110681 · NINDS · OHIO STATE UNIVERSITY · PI TEDESCHI, ANDREA · 2019 to 2023
$1.7M
Cellular and molecular mechanisms of maladaptive homeostatic plasticity and chronic neurodegenerationR21NS109787 · NINDS · OHIO STATE UNIVERSITY · PI TEDESCHI, ANDREA · 2019 to 2019
$409k
NINDS NIH HHS P30 NS104177NINDS NIH HHS R01 NS110681NINDS NIH HHS R01 NS118037NINDS NIH HHS R21 NS109787
6 · The paper itself

Abstract

Functional recovery after spinal cord injury (SCI) often proves difficult as physical and mental barriers bar survivors from enacting their designated rehabilitation programs. We recently demonstrated that adult mice administered gabapentinoids, clinically approved drugs prescribed to mitigate chronic neuropathic pain, recovered upper extremity function following cervical SCI. Given that rehabilitative training enhances neuronal plasticity and promotes motor recovery, we hypothesized that the combination of an aerobic-based rehabilitation regimen like treadmill training with gabapentin (GBP) administration will maximize recovery in SCI mice by strengthening synaptic connections along the sensorimotor axis. Whereas mice administered GBP recovered forelimb functions over the course of weeks and months following SCI, no additive forelimb recovery as the result of voluntary treadmill training was noted in these mice. To our surprise, we also failed to find an additive effect in mice administered vehicle. As motivation is crucial in rehabilitation interventions, we scored active engagement toward the rehabilitation protocol and found that mice administered GBP were consistently participating in the rehabilitation program. In contrast, mice administered vehicle exhibited a steep decline in participation, especially at chronic time points. Whereas neuroinflammatory gene expression profiles were comparable between experimental conditions, we discovered that mice administered GBP had increased hippocampal neurogenesis and exhibited less anxiety-like behavior after SCI. We also found that an external, social motivator effectively rescues participation in mice administered vehicle and promotes forelimb recovery after chronic SCI. Thus, not only does a clinically relevant treatment strategy preclude the deterioration of mental health after chronic SCI, but group intervention strategies may prove to be physically and emotionally beneficial for SCI individuals.

Indexed as

functional recoverygabapentinoidsgroup interventionmental healthneurogenesisspinal cord injury

Identifiers

PMID35875670
PMCPMC9301320
OpenAlexW4284712777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.